Viewing Study NCT06188559


Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2025-12-26 @ 12:49 AM
Study NCT ID: NCT06188559
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-25
First Post: 2023-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer
Sponsor: Eisai Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module